
|Articles|October 15, 2018
PAREXEL and Datavant Partner to Deliver Data and Real-World Evidence Analytics
Advertisement
PAREXEL and Datavant, Inc., a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets, announced they are partnering toward clinical study design and operations, as well as the generation of RWE. The collaboration hopes to enable the linking of healthcare data from a variety of real-world and clinical study data.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
Is Artificial Intelligence Coming for Clinical Research?
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5






.png)



.png)



.png)
.png)
